We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
Cap. Flow
+$1.37B
Cap. Flow %
18.68%
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$306M
2
CI icon
Cigna
CI
+$151M
3
PCRX icon
Pacira BioSciences
PCRX
+$143M
4
ENDP
Endo International plc
ENDP
+$120M
5
THC icon
Tenet Healthcare
THC
+$99.1M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$64.7M
2
BCR
CR Bard Inc.
BCR
+$62.4M
3
PRGO icon
Perrigo
PRGO
+$52.7M
4
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$49.4M
5
SKX
Skechers
SKX
+$47.1M

Sector Composition

Rank Sector Weight
1 Healthcare 50.8%
2 Financials 7.09%
3 Consumer Discretionary 5.97%
4 Energy 5.17%
5 Industrials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S
851
DELISTED
Sprint Corporation
S
$55K ﹤0.01%
14,440
-11,360
-44% -$47.9K
TAC icon
852
TransAlta
TAC
$3.95B
$53K ﹤0.01%
+11,374
New +$64.9K
ARRY
853
DELISTED
Array Biopharma Inc
ARRY
$52K ﹤0.01%
+11,300
New +$67K
GTE icon
854
Gran Tierra Energy
GTE
$265M
$48K ﹤0.01%
+2,239
New +$52.1K
IVAC
855
DELISTED
Intevac Inc
IVAC
$47K ﹤0.01%
+10,200
New +$51.7K
CRC
856
DELISTED
California Resources Corporation
CRC
$45K ﹤0.01%
1,730
+132
+8% +$5.17K
RIGL icon
857
Rigel Pharmaceuticals
RIGL
$681M
$30K ﹤0.01%
1,200
-313
-21% -$9.34K
ETRM
858
DELISTED
EnteroMedics Inc.
ETRM
$26K ﹤0.01%
95
– –
BXE
859
DELISTED
Bellatrix Exploration Ltd.
BXE
$21K ﹤0.01%
+2,769
New +$25.8K
CYHHZ
860
CALL
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
45,544
-231,052
-84% -$2.87K
CYHHZ
861
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$2K ﹤0.01%
+225,919
New +$2.8K
AA icon
862
Alcoa
AA
$11.9B
– –
-10,196
Closed -$273K
AAL icon
863
CALL
American Airlines Group
AAL
$10.1B
– –
-1,000
Closed -$46K
AAP icon
864
Advance Auto Parts
AAP
$3.35B
– –
-2,579
Closed -$411K
ABBV icon
865
PUT
AbbVie
ABBV
$443B
– –
-429
Closed -$8K
ABT icon
866
Abbott
ABT
$183B
– –
-6,614
Closed -$325K
ACHC icon
867
Acadia Healthcare
ACHC
$2.76B
– –
-3,975
Closed -$311K
ACIC icon
868
American Coastal Insurance
ACIC
$515M
– –
-160,297
Closed -$2.49M
ACM icon
869
Aecom
ACM
$9.3B
– –
-6,400
Closed -$212K
ADP icon
870
Automatic Data Processing
ADP
$106B
– –
-25,232
Closed -$2.02M
AEE icon
871
Ameren
AEE
$30.3B
– –
-6,547
Closed -$247K
AEO icon
872
American Eagle Outfitters
AEO
$2.88B
– –
-34,543
Closed -$595K
AES icon
873
AES
AES
$10.5B
– –
-44,616
Closed -$592K
AGIO icon
874
Agios Pharmaceuticals
AGIO
$1.79B
– –
-3,923
Closed -$436K
AGO icon
875
Assured Guaranty
AGO
$3.66B
– –
-13,102
Closed -$314K
33 34
35
36 37

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.

  • Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
  • Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
  • Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
  • Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
  • Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
  • Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
  • Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.